Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure (Q48252698)
Jump to navigation
Jump to search
scientific article published in February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure |
scientific article published in February 2007 |
Statements
1 reference
Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure (English)
1 reference
Andrew Tonkin
1 reference
Henry Krum
1 reference
Emma Ashton
1 reference
Christopher Reid
1 reference
Victor Kalff
1 reference
Jim Rogers
1 reference
John Amarena
1 reference
Bhuwan Singh
1 reference
1 February 2007
1 reference
13
1 reference
1
1 reference
1-7
1 reference